Picture of DiaSorin SpA logo

DIA DiaSorin SpA News Story

0.000.00%
it flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Brief: Diasorin Sees 2030 Adj EBITDA Margin At 34%-35%

May 20 (Reuters) - DiaSorin SpA DIAS.MI:

SEES 2026 REVENUE GROWTH OF 5%-6%, 2026-2030 CAGR OF 6%-8%

SEES 2026 ADJUSTED EBITDA MARGIN AT 32%-33%, 2030 AT 34%-35%

SEES CUMULATIVE FREE CASH FLOW 2027-2030 AT ABOUT €1 BILLION

Further company coverage: DIAS.MI

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on DiaSorin SpA

See all news